Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

714
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
714
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

522
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
522
T Cell Types and Functions01:24

T Cell Types and Functions

613
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
613
Special Features of Adaptive Immunity01:20

Special Features of Adaptive Immunity

593
The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
593
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

1.1K
The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
1.1K
Tumor Immunotherapy01:27

Tumor Immunotherapy

394
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
394

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Selective Glucocorticoid Receptor Modulators of Immune Checkpoint Function.

bioRxiv : the preprint server for biologyĀ·2026
Same author

Negative regulation of T<sub>H</sub>17-mediated inflammation by the nuclear receptor REV-ERBĪ².

bioRxiv : the preprint server for biologyĀ·2026
Same author

Genetic Loss of RORĪ± Impairs Visual Function With Rod Bipolar Cell Degeneration In Mice.

Investigative ophthalmology & visual scienceĀ·2025
Same author

Immune signature clues are key to unlocking the mystery of clinical responses.

Science immunologyĀ·2025
Same author

A tethering mechanism underlies Pin1-catalyzed proline <i>cis-trans</i> isomerization at a noncanonical site.

Proceedings of the National Academy of Sciences of the United States of AmericaĀ·2025
Same author

Advancing clinical response against glioblastoma: Evaluating SHP1705 CRY2 activator efficacy in preclinical models and safety in phase I trials.

Neuro-oncologyĀ·2025

Related Experiment Video

Updated: May 7, 2025

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model
11:31

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model

Published on: August 16, 2019

7.8K

SNIPR alert! Making T cells more precise killers.

Jonathan Chuck1,2, Laura A Solt1,2

  • 1Department of Immunology and Microbiology, Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology, Jupiter, FL 33458, USA.

Science Immunology
|January 3, 2025
PubMed
Summary

Precise control over cell signaling pathways is now possible. This cell engineering strategy utilizes both natural and artificial molecules for targeted regulation.

More Related Videos

Killer Artificial Antigen Presenting Cells KaAPC for Efficient In Vitro Depletion of Human Antigen-specific T Cells
08:12

Killer Artificial Antigen Presenting Cells KaAPC for Efficient In Vitro Depletion of Human Antigen-specific T Cells

Published on: August 11, 2014

9.7K
Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses
10:13

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Published on: May 6, 2019

8.9K

Related Experiment Videos

Last Updated: May 7, 2025

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model
11:31

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model

Published on: August 16, 2019

7.8K
Killer Artificial Antigen Presenting Cells KaAPC for Efficient In Vitro Depletion of Human Antigen-specific T Cells
08:12

Killer Artificial Antigen Presenting Cells KaAPC for Efficient In Vitro Depletion of Human Antigen-specific T Cells

Published on: August 11, 2014

9.7K
Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses
10:13

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Published on: May 6, 2019

8.9K

Area of Science:

  • Cellular biology
  • Molecular engineering

Background:

  • Cell signaling pathways are crucial for cellular functions.
  • Dysregulation of cell signaling contributes to various diseases.
  • Existing methods for controlling cell signaling have limitations.

Purpose of the Study:

  • To develop a novel cell engineering approach for precise cell signaling regulation.
  • To investigate the efficacy of using both endogenous and synthetic ligands.

Main Methods:

  • Employing advanced cell engineering techniques.
  • Designing and synthesizing novel ligands.
  • Utilizing both naturally occurring and engineered ligands to modulate specific signaling pathways.

Main Results:

  • Demonstrated precise control over key cell signaling pathways.
  • Validated the effectiveness of both endogenous and synthetic ligands in modulating signaling.
  • Showcased the potential for targeted therapeutic interventions.

Conclusions:

  • Cell engineering offers a powerful platform for fine-tuning cell communication.
  • The combined use of endogenous and synthetic ligands provides a versatile toolkit for signal modulation.
  • This approach holds promise for advancing cell-based therapies and understanding cellular mechanisms.